Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.61 |
| ▸ | GLP1R | P43220 | 6/20 | 0.59 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.57 |
| ▸ | GCGR | P47871 | 1/20 | 0.56 |
| ▸ | GIPR | P48546 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.55 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.55 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.55 |
| ▸ | CALCR | P30988 | 1/20 | 0.55 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30836920 | 0.93 | TFPI (0.66) | TFPIGLP1RVIPR1GCGRGIPR | |
| SCHEMBL30271991 | 0.93 | TFPI (0.66) | TFPIGLP1RVIPR1ECE1MUS81 | |
| SCHEMBL30271990 | 0.93 | TFPI (0.67) | TFPIGLP1RVIPR1ECE1MUS81 | |
| SCHEMBL30861920 | 0.91 | TFPI (0.65) | TFPIGLP1RVIPR1ECE1MUS81 | |
| SCHEMBL30607319 | 0.90 | TFPI (0.71) | TFPIGLP1RVIPR1GCGRGIPR | |
| SCHEMBL30576973 | 0.89 | GLP1R (0.64) | TFPIGLP1RVIPR1 | |
| SCHEMBL30120636 | 0.89 | TFPI (0.66) | TFPIGLP1RVIPR1NR3C1 | |
| SCHEMBL30721553 | 0.89 | TFPI (0.66) | TFPIGLP1RVIPR1ECE1MUS81 | |
| SCHEMBL30721600 | 0.88 | TFPI (0.64) | TFPIGLP1RVIPR1GCGRGIPR | |
| SCHEMBL30429902 | 0.88 | TFPI (0.68) | TFPIGLP1RVIPR1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263881-A1 | Vaccine compositions for SARS-related coronaviruses and methods of use | ASCIONE RICHARD (US) | 2023-08-24 | — | — | US | disclosed |